rss

Author index

June 1997, Volume 50, Issue 3

[Table of contents][Advertising PDF]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

B

  1. Berry, P J

    • Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Path 1997;50:138-144 doi:10.1136/mp.50.3.138

  2. Boddy, S M

    • Modification of IgH PCR clonal analysis by the addition of sucrose and cresol red directly to PCR reaction mixes. Mol Path 1997;50:164-166 doi:10.1136/mp.50.3.164

  3. Boyce, B F

    • Apoptosis in bone physiology and disease. Mol Path 1997;50:132-137 doi:10.1136/mp.50.3.132

  4. Brandtzaeg, P

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

  5. Buttle, D J

    • "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. Mol Path 1997;50:153-159 doi:10.1136/mp.50.3.153

C

  1. Carr, N J

    • In situ end labelling: effect of proteolytic enzyme pretreatment and hydrochloric acid. Mol Path 1997;50:160-163 doi:10.1136/mp.50.3.160

  2. Charles, A K

    • Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Path 1997;50:138-144 doi:10.1136/mp.50.3.138

  3. Cooper, K

    • Human papillomavirus and schistosomiasis associated bladder cancer. Mol Path 1997;50:145-148 doi:10.1136/mp.50.3.145

D

  1. Dale, I

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

  2. Deacon, E M

    • Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Path 1997;50:124-131 doi:10.1136/mp.50.3.124

F

  1. Fagerhol, M K

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

  2. Fowles, A

    • "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. Mol Path 1997;50:153-159 doi:10.1136/mp.50.3.153

  3. Fox, J E

    • A laboratory guide to biotin labelling in biomolecule analysis Mol Path 1997;50:167 doi:10.1136/mp.50.3.167-c

G

  1. Griffiths, G

    • Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Path 1997;50:124-131 doi:10.1136/mp.50.3.124

H

  1. Haffajee, Z

    • Human papillomavirus and schistosomiasis associated bladder cancer. Mol Path 1997;50:145-148 doi:10.1136/mp.50.3.145

  2. Handley, C J

    • "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. Mol Path 1997;50:153-159 doi:10.1136/mp.50.3.153

  3. Hillhouse, E W

    • Molecular biology of multiple sclerosis Mol Path 1997;50:167 doi:10.1136/mp.50.3.167-b

  4. Hodges, E

    • Modification of IgH PCR clonal analysis by the addition of sucrose and cresol red directly to PCR reaction mixes. Mol Path 1997;50:164-166 doi:10.1136/mp.50.3.164

  5. Hughes, D E

    • Apoptosis in bone physiology and disease. Mol Path 1997;50:132-137 doi:10.1136/mp.50.3.132

I

  1. Ilic, M Z

    • "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. Mol Path 1997;50:153-159 doi:10.1136/mp.50.3.153

J

  1. Jefferis, R

    • Immunoglobulin gene expression in development and disease Mol Path 1997;50:167 doi:10.1136/mp.50.3.167-a

  2. Johne, B

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

L

  1. Lord, J M

    • Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Path 1997;50:124-131 doi:10.1136/mp.50.3.124

  2. Lyberg, T

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

M

  1. Mall, S

    • Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Path 1997;50:138-144 doi:10.1136/mp.50.3.138

  2. Mamaev, N N

    • Nucleoli and AgNORs in Hodgkin's disease. Mol Path 1997;50:149-152 doi:10.1136/mp.50.3.149

  3. Markochev, A B

    • Nucleoli and AgNORs in Hodgkin's disease. Mol Path 1997;50:149-152 doi:10.1136/mp.50.3.149

  4. Medvedeva, N V

    • Nucleoli and AgNORs in Hodgkin's disease. Mol Path 1997;50:149-152 doi:10.1136/mp.50.3.149

N

  1. Naess-Andresen, C F

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

P

  1. Pasternak, N D

    • Nucleoli and AgNORs in Hodgkin's disease. Mol Path 1997;50:149-152 doi:10.1136/mp.50.3.149

  2. Pongracz, J

    • Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Path 1997;50:124-131 doi:10.1136/mp.50.3.124

  3. Prydz, H

    • Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Path 1997;50:113-123 doi:10.1136/mp.50.3.113

S

  1. Shust, V F

    • Nucleoli and AgNORs in Hodgkin's disease. Mol Path 1997;50:149-152 doi:10.1136/mp.50.3.149

  2. Smith, J L

    • Modification of IgH PCR clonal analysis by the addition of sucrose and cresol red directly to PCR reaction mixes. Mol Path 1997;50:164-166 doi:10.1136/mp.50.3.164

T

  1. Talbot, I C

    • In situ end labelling: effect of proteolytic enzyme pretreatment and hydrochloric acid. Mol Path 1997;50:160-163 doi:10.1136/mp.50.3.160

  2. Taylor, L

    • Human papillomavirus and schistosomiasis associated bladder cancer. Mol Path 1997;50:145-148 doi:10.1136/mp.50.3.145

  3. Thomas, S

    • Modification of IgH PCR clonal analysis by the addition of sucrose and cresol red directly to PCR reaction mixes. Mol Path 1997;50:164-166 doi:10.1136/mp.50.3.164

W

  1. Watson, J

    • Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Path 1997;50:138-144 doi:10.1136/mp.50.3.138

    • Pathology jobs

    Pathology jobs

    Show me all >>